healthcare
healthcare Articles
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
Published:
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
Published:
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Published:
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
Published:
OpGen shares jumped on Thursday after the company announced that it will be joining the fight against the latest coronavirus outbreak.
Published:
Clinical-stage, drug platform company Annovis Bio entered the market with a bang on Wednesday.
Published:
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Published:
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the economic...
Published:
Last Updated:
Cannabis stocks took a beating Friday after an analyst's comment that supplies would remain tight this year. But that's not all that's wrong in the pot sector.
Published:
As the bad news piled up for CannTrust last year, the rest of the cannabis industry also imploded. What to expect from CannTrust in 2020 is a glass either half-empty or half-full.
Published: